The care and feeding of a commercial liposomal product: liposomal amphotericin B (AmBisome®)
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Liposome Research"
DOI: 10.1080/08982104.2017.1380664
Abstract: Abstract AmBisome (liposomal amphotericin B) is among the earliest approved liposomal therapeutics, and has been in commercial use since the early 1990s. This review provides examples of non-clinical, regulatory, clinical label expansion, adverse event management,… read more here.
Keywords: liposomal product; liposomal amphotericin; product; commercial liposomal ... See more keywords